RegMed XB is awarded to be one of the selected programs by Health~Holland
In October last year, RegMed XB applied for a 3-year Public-Private Partnership (PPS) subsidy program, called 'Regenerative Medicine Translational Synergy'. Today, we can announce that RegMed XB’s 3-year PPS program has been awarded by Health~Holland for €2 million in 2025, with reservations for the same amount in 2026 and 2027.
This program focuses on translational public-private partnership projects within the field of regenerative medicine, which enables consortia of businesses and research institutions to apply for funding to accelerate groundbreaking projects in the Life Sciences & Health sector.
RegMed XB focuses on Regenerative Medicine (RG), a promising field with the potential to restore or replace damaged tissues and organs. Together with public and private partners, RegMed XB is developing ambitious moonshots to push forward RG solutions for significant patient needs. This program is not just transforming healthcare but also strengthening the economy through innovation and collaboration.
On behalf of the entire RegMed XB team, we would like to extend gratitude to everyone who supported our application. Your suggestions and shared examples, brainstorming sessions, and any other support contributed to this award success.
